NL7311069A - - Google Patents

Info

Publication number
NL7311069A
NL7311069A NL7311069A NL7311069A NL7311069A NL 7311069 A NL7311069 A NL 7311069A NL 7311069 A NL7311069 A NL 7311069A NL 7311069 A NL7311069 A NL 7311069A NL 7311069 A NL7311069 A NL 7311069A
Authority
NL
Netherlands
Application number
NL7311069A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7311069A publication Critical patent/NL7311069A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/36Compounds containing oxirane rings with hydrocarbon radicals, substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NL7311069A 1972-08-11 1973-08-10 NL7311069A (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3755072A GB1382526A (en) 1972-08-11 1972-08-11 Morpholine derivatives

Publications (1)

Publication Number Publication Date
NL7311069A true NL7311069A (en:Method) 1974-02-13

Family

ID=10397311

Family Applications (2)

Application Number Title Priority Date Filing Date
NL7311069A NL7311069A (en:Method) 1972-08-11 1973-08-10
NL7311068A NL7311068A (en:Method) 1972-08-11 1973-08-10

Family Applications After (1)

Application Number Title Priority Date Filing Date
NL7311068A NL7311068A (en:Method) 1972-08-11 1973-08-10

Country Status (22)

Country Link
US (2) US3974158A (en:Method)
JP (2) JPS572710B2 (en:Method)
AT (8) AT327930B (en:Method)
AU (2) AU471402B2 (en:Method)
BE (2) BE803284A (en:Method)
CH (4) CH594642A5 (en:Method)
CS (4) CS183681B2 (en:Method)
DD (2) DD108299A5 (en:Method)
DE (2) DE2340874A1 (en:Method)
DK (1) DK135505B (en:Method)
ES (1) ES417796A1 (en:Method)
FR (2) FR2195448B1 (en:Method)
GB (1) GB1382526A (en:Method)
HU (2) HU166870B (en:Method)
IE (1) IE37928B1 (en:Method)
IL (2) IL42841A (en:Method)
IN (1) IN137769B (en:Method)
NL (2) NL7311069A (en:Method)
PL (4) PL95166B1 (en:Method)
SE (1) SE385889B (en:Method)
SU (7) SU537627A3 (en:Method)
ZA (2) ZA735008B (en:Method)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1064927A (en) * 1975-01-29 1979-10-23 Yuji Kawashima Process of producing 2-(indenyloxymethyl) morpholine derivatives
IL56369A (en) * 1978-01-20 1984-05-31 Erba Farmitalia Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them
GB2184438B (en) * 1985-12-19 1990-10-03 Ici Plc Heterocyclic compounds
GB8827152D0 (en) * 1988-11-21 1988-12-29 Wellcome Found Anti-atherosclerotic diaryl compounds
US5290814A (en) * 1988-11-21 1994-03-01 Burroughs Wellcome Co. Anti-atherosclerotic diaryl compounds
EP0507488A1 (en) * 1991-03-27 1992-10-07 Merck & Co. Inc. Inhibitors of HIV-1 reverse transcriptase
WO1993015052A1 (en) * 1992-01-28 1993-08-05 Smithkline Beecham Plc Compounds as calcium channel antagonists
AU4455397A (en) 1996-08-23 1998-03-06 Neurosearch A/S Disubstituted morpholine, oxazepine or thiazepine derivatives, their preparation and their use as dopamine d4 receptor antagonists
AU777760B2 (en) * 1999-05-25 2004-10-28 Sepracor, Inc. Heterocyclic analgesic compounds and methods of use thereof
US6645980B1 (en) 2000-05-25 2003-11-11 Sepracor Inc. Heterocyclic analgesic compounds and methods of use thereof
US6677332B1 (en) 1999-05-25 2004-01-13 Sepracor, Inc. Heterocyclic analgesic compounds and methods of use thereof
US6635661B2 (en) 2000-05-25 2003-10-21 Sepracor Inc. Heterocyclic analgesic compounds and methods of use thereof
US7361666B2 (en) 1999-05-25 2008-04-22 Sepracor, Inc. Heterocyclic analgesic compounds and methods of use thereof
US7294637B2 (en) 2000-09-11 2007-11-13 Sepracor, Inc. Method of treating addiction or dependence using a ligand for a monamine receptor or transporter
CA2422055A1 (en) 2000-09-11 2002-03-21 Sepracor, Inc. Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission)
TW200602299A (en) * 2004-06-24 2006-01-16 Sankyo Co Saturated n-calbonyl heterocyclic compounds, their preparation and the synthetic mediates
TWI452044B (zh) * 2007-06-15 2014-09-11 Mitsubishi Tanabe Pharma Corp 嗎啉衍生物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH386443A (de) * 1959-12-16 1965-01-15 Geigy Ag J R Verfahren zur Herstellung von neuen tetrasubstituierten Alkylendiaminen
GB1138405A (en) * 1966-12-28 1969-01-01 Ici Ltd Morpholine derivatives

Also Published As

Publication number Publication date
AT326675B (de) 1975-12-29
NL7311068A (en:Method) 1974-02-13
SE385889B (sv) 1976-07-26
SU509231A3 (ru) 1976-03-30
ES417796A1 (es) 1976-02-16
FR2195454A1 (en:Method) 1974-03-08
IL42841A0 (en) 1973-10-25
DD108299A5 (en:Method) 1974-09-12
HU167000B (en:Method) 1975-07-28
DK135505C (en:Method) 1977-10-17
ZA735007B (en) 1974-06-26
US3974158A (en) 1976-08-10
HU166870B (en:Method) 1975-06-28
IL42841A (en) 1976-04-30
FR2195448B1 (en:Method) 1977-02-25
AT327931B (de) 1976-02-25
SU508200A3 (ru) 1976-03-25
PL95166B1 (en:Method) 1977-09-30
CH594645A5 (en:Method) 1978-01-13
DK135505B (da) 1977-05-09
ATA974974A (de) 1975-05-15
ATA701773A (de) 1975-05-15
US3974156A (en) 1976-08-10
DE2340874A1 (de) 1974-02-21
IE37928L (en) 1974-02-11
AU468101B2 (en) 1975-12-18
SU508199A3 (ru) 1976-03-25
BE803283A (fr) 1974-02-06
AU5848573A (en) 1975-01-30
JPS49124079A (en:Method) 1974-11-27
AT327932B (de) 1976-02-25
PL91728B1 (en:Method) 1977-03-31
JPS572710B2 (en:Method) 1982-01-18
CH594644A5 (en:Method) 1978-01-13
GB1382526A (en) 1975-02-05
SU537627A3 (ru) 1976-11-30
CH594642A5 (en:Method) 1978-01-13
AU471402B2 (en) 1976-04-29
SU503521A3 (ru) 1976-02-15
AT327929B (de) 1976-02-25
DD107931A5 (en:Method) 1974-08-20
AT327210B (de) 1976-01-26
JPS5046675A (en:Method) 1975-04-25
CS182790B2 (en) 1978-05-31
CS182799B2 (en) 1978-05-31
SU508201A3 (ru) 1976-03-25
CS183681B2 (en) 1978-07-31
ATA701673A (de) 1975-06-15
PL91729B1 (en:Method) 1977-03-31
AT328460B (de) 1976-03-25
AU5849173A (en) 1975-01-30
ATA975074A (de) 1975-05-15
ZA735008B (en) 1974-06-26
ATA924974A (de) 1975-03-15
SU521844A3 (ru) 1976-07-15
BE803284A (fr) 1974-02-06
IN137769B (en:Method) 1975-09-13
AT327930B (de) 1976-02-25
ATA925074A (de) 1975-04-15
CH594646A5 (en:Method) 1978-01-13
PL90322B1 (en:Method) 1977-01-31
IL42842A0 (en) 1973-10-25
CS182798B2 (en) 1978-05-31
IE37928B1 (en) 1977-11-09
ATA974874A (de) 1975-05-15
FR2195454B1 (en:Method) 1977-02-25
DE2340873A1 (de) 1974-02-28
FR2195448A1 (en:Method) 1974-03-08

Similar Documents

Publication Publication Date Title
JPS4992304A (en:Method)
FR2192892A1 (en:Method)
FR2195454B1 (en:Method)
JPS527385B2 (en:Method)
JPS4932709A (en:Method)
JPS4931308A (en:Method)
JPS4923698A (en:Method)
JPS4938205Y2 (en:Method)
JPS5145939B2 (en:Method)
JPS5325451B2 (en:Method)
JPS5443699B2 (en:Method)
JPS4938457U (en:Method)
FR2199025A1 (en:Method)
CS150338B1 (en:Method)
JPS497157U (en:Method)
CH605668A5 (en:Method)
CH601027A5 (en:Method)
CH576134B5 (en:Method)
CH599222A5 (en:Method)
AU479996A (en:Method)
CH595439A5 (en:Method)
CH592915B5 (en:Method)
CH559858A5 (en:Method)
CH559065A5 (en:Method)
BE783740A (en:Method)